Malte Simon

Malte Simon

Auto-generated profile, based on publicly available information

Malte Simon

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Immunity
Verified
Journal Article
Open access
MDMichael Delacher
Michael Delacher
MSMalte Simon
Malte Simon
LSLieke Sanderink
Lieke Sanderink
AHAgnes Hotz-Wagenblatt
Agnes Hotz-Wagenblatt
MWMarina Wuttke
Marina Wuttke
MFMarkus Feuerer
Markus Feuerer
Murine regulatory T (Treg) cells in tissues promote tissue homeostasis and regeneration. We sought to identify features that characterize human Treg cells with these functions in healthy tissues. Single-cell chromatin accessibility profiles of murine and human tissue Treg cells defined a conserved, microbiota-independent tissue-repair Treg signature with a prevailing footprint of the transcription factor BATF. This signature, combined with gene expression profiling and TCR fate mapping, identified a population of tissue-like Treg cells in human peripheral blood that expressed BATF, chemokine receptor CCR8 and HLA-DR. Human BATF+CCR8+ Treg cells from normal skin and adipose tissue shared features with nonlymphoid T follicular helper-like (Tfh-like) cells, and induction of a Tfh-like differentiation program in naive human Treg cells partially recapitulated tissue Treg regenerative characteristics, including wound healing potential. Human BATF+CCR8+ Treg cells from healthy tissue share features with tumor-resident Treg cells, highlighting the importance of understanding the context-specific functions of these cells.

16 January 2024 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MDMichael Delacher
Michael Delacher
LSLisa Schmidleithner
Lisa Schmidleithner
MSMalte Simon
Malte Simon
PSPhilipp Stüve
Philipp Stüve
LSLieke Sanderink
Lieke Sanderink
MFMarkus Feuerer
Markus Feuerer
CD8 T lymphocytes are classically viewed as cytotoxic T cells. Whether human CD8 T cells can, in parallel, induce a tissue regeneration program is poorly understood. Here, antigen-specific assay systems revealed that human CD8 T cells not only mediated cytotoxicity but also promoted tissue remodeling. Activated CD8 T cells could produce the epidermal growth factor receptor (EGFR)-ligand amphiregulin (AREG) and sensitize epithelial cells for enhanced regeneration potential. Blocking the EGFR or the effector cytokines IFN-γ and TNF could inhibit tissue remodeling. This regenerative program enhanced tumor spheroid and stem cell–mediated organoid growth. Using single-cell gene expression analysis, we identified an AREG+, tissue-resident CD8 T cell population in skin and adipose tissue from patients undergoing abdominal wall or abdominoplasty surgery. These tissue-resident CD8 T cells showed a strong TCR clonal relation to blood PD1+TIGIT+ CD8 T cells with tissue remodeling abilities. These findings may help to understand the complex CD8 biology in tumors and could become relevant for the design of therapeutic T cell products.

29 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NENiklas L. Engel
Niklas L. Engel
HFHanna Frieß
Hanna Frieß
JGJulia Grigorjew
Julia Grigorjew
FPFerdinand Popp
Ferdinand Popp
LHLea Herzel
Lea Herzel
LFLars Feuerbach
Lars Feuerbach
Introduction Biological processes such as aging, carcinogenesis, and immune response rely on the ability to maintain or rapidly expand cell populations. The fitness of the involved cells is constrained by their replicative potential, which is reflected in the cellular telomere content. Method We apply TelomereHunter to scATAC-seq data to determine telomere content on single-cell level, in a hematopoietic dataset consisting of 35,139 cells from samples of basal cell carcinoma patients receiving programmed cell death protein 1 (PD1) blockade treatment. Integrating information from open-chromatin-based signatures to assess cell identity, we characterize the heterogeneity of telomere length for individual cell populations pre- and post-immunotherapy. Results The extracted telomeric reads reflect the expected telomereome-to-genome fraction. Telomere content distributions differ significantly between cell populations, and the median telomere content in intermediate and terminal exhausted CD8+ T-cells pre-treatment is significantly correlated to response to PD-1 checkpoint blockade. Likewise, telomere content correlates with post-treatment cell proliferation in terminally exhausted and T follicular helper cells from responding patients. Conclusion Telomere content measurement from scATAC-seq data has a sufficiently high signal-to-noise ratio to detect significant differences between cell types. Furthermore, the telomere content of CD8+ exhausted T-cells pre-treatment is a putative biomarker for successful PD-1-based immunotherapy.

17 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
KBKathrin Luise Braband
Kathrin Luise Braband
TKTamara Kaufmann
Tamara Kaufmann
NBNiklas Beumer
Niklas Beumer
MSMalte Simon
Malte Simon
SHSara Salome Helbich
Sara Salome Helbich
MDMichael Delacher
Michael Delacher
Regulatory T (Treg) cells, a subset of CD4 + T cells, play a crucial role in immunoregulation. Notably, CCR8-expressing Treg cells in tissues also contribute to organ homeostasis and repair. To determine whether these tissue-regenerative programs are active in the tumor microenvironment, we employed single-cell chromatin accessibility and genome-wide DNA methylation analyses to investigate CCR8 + tissue Treg cells isolated from human tumor and adjacent tumor-free tissues. Our findings indicate that CCR8 + tissue Treg cells from tumor and corresponding tumor-free tissues exhibit a high degree of similarity, suggesting that the tumor microenvironment may harbor highly activated tissue Treg cells. This observation was consistent across various tumor types and origins, including primary tumors and metastases. Using quantitative proteomics, we identified several candidate factors associated with the regenerative and suppressive programs of Treg cells, which may serve as potential reservoir of druggable targets for future therapeutic interventions.

1 January 1998
Verified
Book Chapter
Closed access
PDF file
ARA. Reichert
A. Reichert
ELE. Lengfelder
E. Lengfelder
WSWolfgang Seifarth
Wolfgang Seifarth
AHA. Hochhaus
A. Hochhaus
SSS. Saussele
S. Saussele
RHRüdiger Hehlmann
Rüdiger Hehlmann